Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.

Introduction: Description of the cutaneous side effects of erlotinib.

Materials: Report with images of a single case.

Methods: Case report and review of the literature.

Conclusion: Erlotinib is associated with significant cutaneous toxicity which should be recognised and managed appropriately.